Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Norwegian (OSEAX) Biotech Industry Analysis

UpdatedAug 08, 2026
DataAggregated Company Financials
Companies8
  • 7D-2.6%
  • 3M2.9%
  • 1Y40.6%
  • YTD9.2%

The Biotech industry is up 3.5% in the last week, with Circio Holding up 7.0%. During this same period, the Thor Medical underperformed, falling 6.2%. This means that the industry has gained 39% over the past year. Earnings are forecast to grow by 23% annually.

Industry Valuation and Performance

Has the Norwegian Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 08 Aug 2026NOK 5.9bNOK 177.2m-NOK 520,062,669.0974.7x-11.4x33.5x
Mon, 06 Jul 2026NOK 5.5bNOK 177.4m-NOK 524,905,857.7474.9x-10.4x30.9x
Wed, 03 Jun 2026NOK 5.6bNOK 548.9m-NOK 390,472,783.7541.1x-14.4x10.3x
Fri, 01 May 2026NOK 5.7bNOK 541.1m-NOK 366,641,068.4058.3x-15.7x10.6x
Sun, 29 Mar 2026NOK 5.5bNOK 545.9m-NOK 378,219,542.6050.8x-14.6x10.1x
Tue, 24 Feb 2026NOK 5.6bNOK 611.0m-NOK 365,072,529.1662.2x-15.4x9.2x
Thu, 22 Jan 2026NOK 5.3bNOK 606.1m-NOK 366,843,812.3477.9x-14.3x8.7x
Sat, 20 Dec 2025NOK 5.0bNOK 607.4m-NOK 368,701,610.0679.4x-13.7x8.3x
Mon, 17 Nov 2025NOK 4.7bNOK 612.9m-NOK 429,056,045.1281.4x-10.9x7.6x
Wed, 15 Oct 2025NOK 4.8bNOK 613.1m-NOK 520,612,083.59254x-9.2x7.8x
Fri, 12 Sep 2025NOK 4.8bNOK 612.8m-NOK 491,526,545.36245.8x-9.7x7.8x
Sun, 10 Aug 2025NOK 4.8bNOK 886.7m-NOK 749,763,853.03224.7x-6.4x5.4x
Tue, 08 Jul 2025NOK 4.8bNOK 885.3m-NOK 745,378,255.83199.7x-6.4x5.4x
Thu, 05 Jun 2025NOK 4.6bNOK 885.2m-NOK 745,018,191.21185.7x-6.2x5.2x
Sat, 03 May 2025NOK 4.6bNOK 519.6m-NOK 1,017,926,030.51112x-4.5x8.9x
Mon, 31 Mar 2025NOK 4.6bNOK 520.4m-NOK 918,625,294.70110.1x-5x8.8x
Wed, 26 Feb 2025NOK 5.4bNOK 471.8m-NOK 1,117,223,421.98125.5x-4.8x11.4x
Fri, 24 Jan 2025NOK 5.1bNOK 457.2m-NOK 1,070,419,635.88154.5x-4.7x11.1x
Sun, 22 Dec 2024NOK 4.5bNOK 457.5m-NOK 1,072,731,079.48148.5x-4.2x9.8x
Tue, 19 Nov 2024NOK 3.7bNOK 484.0m-NOK 1,065,358,188.10147.7x-3.4x7.6x
Thu, 17 Oct 2024NOK 4.7bNOK 471.9m-NOK 1,069,434,351.3055.9x-4.4x10x
Sat, 14 Sep 2024NOK 5.3bNOK 470.2m-NOK 1,052,958,592.9060.1x-5x11.3x
Mon, 12 Aug 2024NOK 8.1bNOK 515.6m-NOK 1,048,313,840.8569.8x-7.7x15.7x
Wed, 10 Jul 2024NOK 8.5bNOK 513.4m-NOK 1,040,267,893.0969.8x-8.2x16.6x
Fri, 07 Jun 2024NOK 9.2bNOK 640.8m-NOK 938,122,873.7937.5x-9.8x14.3x
Sun, 05 May 2024NOK 8.7bNOK 658.3m-NOK 957,096,317.7235.9x-9.1x13.2x
Tue, 02 Apr 2024NOK 9.2bNOK 658.7m-NOK 944,695,486.6640.9x-9.8x14x
Thu, 29 Feb 2024NOK 14.4bNOK 673.0m-NOK 1,006,746,085.6641x-14.3x21.4x
Sat, 27 Jan 2024NOK 16.5bNOK 656.0m-NOK 1,357,631,062.0059.2x-12.2x25.2x
Mon, 25 Dec 2023NOK 15.8bNOK 653.0m-NOK 1,348,996,802.0060.5x-11.7x24.3x
Wed, 22 Nov 2023NOK 16.1bNOK 659.7m-NOK 1,368,362,220.0056.3x-11.7x24.4x
Fri, 20 Oct 2023NOK 15.7bNOK 489.4m-NOK 1,552,480,866.0096.4x-10.1x32.1x
Sun, 17 Sep 2023NOK 15.4bNOK 625.5m-NOK 1,462,609,751.0056.8x-10.6x24.7x
Tue, 15 Aug 2023NOK 16.6bNOK 558.5m-NOK 1,465,738,903.0053.1x-11.3x29.7x
Price to Earnings Ratio

-11.3x


Total Market Cap: NOK 16.6bTotal Earnings: -NOK 1,465,738,903.00Total Revenue: NOK 558.5mTotal Market Cap vs Earnings and Revenue0%0%0%
Norwegian Biotech Industry Price to Earnings3Y Average -9.4x202420252026
Current Industry PE
  • Investors are optimistic on the Norwegian Biotechs industry, and appear confident in long term growth rates.
  • The industry's 3-year average PS ratio of 13.7x is exceeded by the industry's current PS ratio of 32.9x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have improved over the last three years.
  • Meanwhile revenues for these companies have declined 32% per year.
  • This means that less sales are being generated overall, but since the cost of doing business is lower, losses have been shrinking.

Industry Trends

Which industries have driven the changes within the Norwegian Healthcare industry?

NO Market0.25%
Healthcare-1.61%
Biotech-2.63%
Biotech-2.63%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
CRNA Circio HoldingNOK 8.777.0%
+NOK 135.7m		1,296.5%PE-45.5x
ABS Arctic BioscienceNOK 3.1518.0%
+NOK 12.9m		-14.2%PS2x
EXTX EXACT TherapeuticsNOK 0.757.1%
+NOK 3.2m		-72.0%PS804.2x
AZT ArcticZymes TechnologiesNOK 19.650.3%
+NOK 2.6m		2.6%PE74.7x

Latest News

ABS
NOK 3.15
Arctic Bioscience
7D
18.0%
1Y
-14.2%
TRMED
NOK 5.43
Thor Medical
7D
-6.2%
1Y
128.2%
AZT
NOK 19.65
ArcticZymes Technologies
7D
0.3%
1Y
2.6%
Narrative Update • Jul 29

AZT: New RNA Patent Will Support Future Biomanufacturing Upside

Analysts have trimmed their fair value estimate for ArcticZymes Technologies from NOK32 to NOK28. They point to more measured revenue growth expectations, slightly higher projected profit margins, and a lower future P/E assumption as the key drivers of the change in price target.
NYKD
NOK 3.33
Nykode Therapeutics
7D
-1.5%
1Y
94.7%
Analysis Article • Jul 25

Here's Why We're Watching Nykode Therapeutics' (OB:NYKD) Cash Burn Situation

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
LYTIX
NOK 8.50
Lytix Biopharma
7D
-2.3%
1Y
-9.4%
ZLNA
NOK 22.60
Zelluna
7D
-2.6%
1Y
53.7%
CRNA
NOK 8.77
Circio Holding
7D
7.0%
1Y
1,296.5%
EXTX
NOK 0.75
EXACT Therapeutics
7D
7.1%
1Y
-72.0%